Day One at JP Morgan: Beckman Coulter; Agilent; Waters

A Beckman Coulter official provided an update on revenue guidance and the firm's pending molecular diagnostics system; while an Agilent executive discussed the company's pending Varian acquisition and new UHPLC system.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.